Indaptus Therapeutics Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Jeffrey A Meckler | 3 | 30,000 |
Walt Addison Linscott | 1 | 150 |
Glen R. Anderson | 1 | 103,352 |
Boyan Vesselinov Litchev | 1 | 1,150 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 0 | 0 | 0 |
最近12个月 | 103,352 | 0 | 103,352 |
最近18个月 | 114,502 | 0 | 114,502 |
最近36个月 | 134,652 | 0 | 134,652 |
Indaptus Therapeutics Inc 内部交易
Indaptus Therapeutics Inc 最新内部交易
Glen R. Anderson | 10% Owner | 2023-08-14 | 买入 | 103,352 | 1,190,400 |
$2.09
|
+0.96%
|
Boyan Vesselinov Litchev | Chief Medical Officer | 2022-12-01 | 买入 | 1,150 | 1,150 |
$2.19
|
-3.65%
|
Jeffrey A Meckler | CEO & Director | 2022-11-21 | 买入 | 10,000 | 75,374 |
$1.89
|
+11.64%
|
Jeffrey A Meckler | CEO & Director | 2022-09-08 | 买入 | 10,308 | 65,374 |
$2.8
|
-24.64%
|
Walt Addison Linscott | Chief Business Officer | 2022-09-07 | 买入 | 150 | 150 |
$2.62
|
-19.47%
|
Jeffrey A Meckler | CEO & Director | 2022-09-07 | 买入 | 9,692 | 55,066 |
$2.56
|
-17.58%
|
Jeffrey A Meckler | CEO & Director | 2022-06-06 | 买入 | 19,727 | 45,374 |
$2.63
|
-19.77%
|
Michael James Newman | CSO & Director, 10% Owner | 2022-02-01 | 卖出 | 20,000 | 2,750,842 |
$5
|
-57.80%
|
Jeffrey A Meckler | CEO & Director | 2021-11-18 | 买入 | 11,187 | 25,647 |
$5.82
|
-63.75%
|
Jeffrey A Meckler | CEO & Director | 2021-09-14 | 买入 | 12,000 | 14,460 |
$7
|
-69.86%
|